<DOC>
	<DOCNO>NCT00006481</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell , may cause skin irritation inflammation . Biafine cream may effective lessen side effect cause radiation therapy . PURPOSE : Randomized phase III trial determine effectiveness Biafine cream reduce side effect radiation therapy patient receive treatment head neck cancer .</brief_summary>
	<brief_title>Biafine Cream Reduce Side Effects Radiation Therapy Patients Receiving Treatment Advanced Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare efficacy prophylactic Biafine cream vs standard best supportive care reduce grade 2 high radiation-induced skin toxicity observe radiotherapy patient advance squamous cell carcinoma head neck . II . Determine prophylactic interventional use Biafine cream effective base reduction maximum skin toxicity result radiation treatment patient population . III . Compare quality life patient treatment . IV . Assess toxicity Biafine cream patient . OUTLINE : This randomize study . Patients stratify accord lymph node status ( negative v positive ) , type treatment ( radiation plus chemotherapy v radiation alone ) , radiation fractionation ( standard v concurrent boost ) , radiation dose ( 50-60 Gy v great 60 Gy ) . Patients randomize 1 3 treatment arm . Arm I : Patients receive radiotherapy daily 5 day week 5-8 week , without standard skin cream application ( Biafine cream ) irradiate skin . Arm II : Patients receive radiotherapy arm I , Biafine cream apply skin 3 time daily 7 day week initiation radiotherapy continue 2 week last radiation treatment . Biafine cream apply few 4 hour treatment few 4 hour application . Arm III : Patients receive radiotherapy arm I II , Biafine cream apply arm II skin become symptomatic ( i.e. , redness , dryness , itching , tenderness ) . Quality life assess treatment , weekly treatment , weekly 4 week treatment completion . Patients follow weekly 4 week . PROJECTED ACCRUAL : Approximately 500 patient accrue study within 17 month .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm stage III IV squamous cell carcinoma head neck , include : Oral cavity Oropharyngeal Hypopharyngeal Laryngeal Radiotherapy indicate primary treatment treatment primary surgical resection Primary field receive least 50 Gy No skin rash , ulceration , open wound treatment field No tumor involvement skin PATIENT CHARACTERISTICS : Age : Not specify Performance status : Zubrod 01 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No known skin allergy sensitivity Biafine No inflammatory connective tissue disorder skin No history mental incompetence , include psychological disorder drug dependency disorder , would preclude study compliance PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Concurrent chemotherapy allow Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics No prior radiotherapy treatment field Surgery : See Disease Characteristics Prior surgery allow Other : No concurrent investigational therapy No concurrent participation RTOG clinical trial No concurrent amifostine ( concurrent pilocarpine allow )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>skin reaction secondary radiation therapy</keyword>
</DOC>